Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

NCT02209649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lacidipine and Telmisartan fixed dose combination (FDC) tablet
DRUG: Lacidipine
DRUG: Telmisartan

Sponsor

Boehringer Ingelheim